Filing metadata

Accession number
0001415889-24-012652
Form type
Form 4
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
May 08, 2024
Reporting period
May 06, 2024
Description
Insider transaction

Explore SEC Filings Hub